NURPF
Price
$8.81
Change
-$0.05 (-0.56%)
Updated
Jun 16 closing price
Capitalization
1.18B
NWPHF
Price
$9.36
Change
-$2.64 (-22.00%)
Updated
Sep 9 closing price
Capitalization
176.91M
Interact to see
Advertisement

NURPF vs NWPHF

Header iconNURPF vs NWPHF Comparison
Open Charts NURPF vs NWPHFBanner chart's image
Neuren Pharmaceuticals
Price$8.81
Change-$0.05 (-0.56%)
Volume$375
Capitalization1.18B
Newron Pharmaceuticals SPA
Price$9.36
Change-$2.64 (-22.00%)
Volume$500
Capitalization176.91M
NURPF vs NWPHF Comparison Chart in %
Loading...
NURPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NURPF vs. NWPHF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NURPF is a Hold and NWPHF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (NURPF: $8.81 vs. NWPHF: $9.36)
Brand notoriety: NURPF and NWPHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NURPF: 30% vs. NWPHF: 100%
Market capitalization -- NURPF: $1.18B vs. NWPHF: $176.91M
NURPF [@Biotechnology] is valued at $1.18B. NWPHF’s [@Biotechnology] market capitalization is $176.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NURPF’s FA Score shows that 1 FA rating(s) are green whileNWPHF’s FA Score has 1 green FA rating(s).

  • NURPF’s FA Score: 1 green, 4 red.
  • NWPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, NURPF is a better buy in the long-term than NWPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NURPF’s TA Score shows that 4 TA indicator(s) are bullish.

  • NURPF’s TA Score: 4 bullish, 3 bearish.

Price Growth

NURPF (@Biotechnology) experienced а 0.00% price change this week, while NWPHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NURPF($1.18B) has a higher market cap than NWPHF($177M). NURPF YTD gains are higher at: 16.380 vs. NWPHF (0.000).
NURPFNWPHFNURPF / NWPHF
Capitalization1.18B177M669%
EBITDA108MN/A-
Gain YTD16.3800.000-
P/E Ratio12.33N/A-
Revenue141MN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
NURPF vs NWPHF: Fundamental Ratings
NURPF
NWPHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
519
SMR RATING
1..100
17100
PRICE GROWTH RATING
1..100
5376
P/E GROWTH RATING
1..100
88100
SEASONALITY SCORE
1..100
5043

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NWPHF's Valuation (66) in the null industry is in the same range as NURPF (68). This means that NWPHF’s stock grew similarly to NURPF’s over the last 12 months.

NWPHF's Profit vs Risk Rating (9) in the null industry is somewhat better than the same rating for NURPF (51). This means that NWPHF’s stock grew somewhat faster than NURPF’s over the last 12 months.

NURPF's SMR Rating (17) in the null industry is significantly better than the same rating for NWPHF (100). This means that NURPF’s stock grew significantly faster than NWPHF’s over the last 12 months.

NURPF's Price Growth Rating (53) in the null industry is in the same range as NWPHF (76). This means that NURPF’s stock grew similarly to NWPHF’s over the last 12 months.

NURPF's P/E Growth Rating (88) in the null industry is in the same range as NWPHF (100). This means that NURPF’s stock grew similarly to NWPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NURPFNWPHF
RSI
ODDS (%)
Bearish Trend 4 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
69%
N/A
Momentum
ODDS (%)
Bullish Trend 4 days ago
63%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
59%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
15%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
12%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
67%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
55%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NURPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMCCX6.820.09
+1.34%
Voya MidCap Opportunities C
JEGRX17.750.16
+0.91%
Janus Henderson Global Sust Eq R
RTLAX88.810.76
+0.86%
Russell Inv Tax-Managed US Large Cap A
HSVRX41.870.19
+0.46%
Harbor Small Cap Value Admin
JHAAX10.330.03
+0.29%
JHancock Multi-Asset Absolute Return A

NURPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NURPF has been loosely correlated with CGEN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NURPF jumps, then CGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NURPF
1D Price
Change %
NURPF100%
N/A
CGEN - NURPF
46%
Loosely correlated
+1.15%
ASPHF - NURPF
30%
Poorly correlated
N/A
SPHRF - NURPF
22%
Poorly correlated
N/A
KRRO - NURPF
21%
Poorly correlated
+1.99%
GDTC - NURPF
21%
Poorly correlated
+3.61%
More

NWPHF and

Correlation & Price change

A.I.dvisor tells us that NWPHF and MMIRF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NWPHF and MMIRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NWPHF
1D Price
Change %
NWPHF100%
N/A
MMIRF - NWPHF
30%
Poorly correlated
-74.07%
ACET - NWPHF
27%
Poorly correlated
-1.14%
IGXT - NWPHF
23%
Poorly correlated
N/A
NTRB - NWPHF
19%
Poorly correlated
N/A
NURPF - NWPHF
7%
Poorly correlated
N/A
More